Orchestration of pulmonary t cell immunity during mycobacterium tuberculosis infection: Immunity interruptus

Seminars in Immunology

Volumn 26, Issue 6, 2014, Pages 559-577

  Behar, Samuel M ^a   Carpenter, Stephen M ^a,b   Booty, Matthew G ^a,c   Barber, Daniel L ^d   Jayaraman, Pushpa ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cytokine; Exhaustion; Memory; Priming; T cell; Tuberculosis

Indexed keywords

CHEMOKINE; EPITOPE; BCG VACCINE; CYTOKINE;

ANTIGEN PRESENTATION; CELLULAR IMMUNITY; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; LUNG PARENCHYMA; MACROPHAGE FUNCTION; MEMORY T LYMPHOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; ADAPTIVE IMMUNITY; DENDRITIC CELL; IMMUNE EVASION; IMMUNOLOGY; INNATE IMMUNITY; LUNG; LYMPH NODE; MACROPHAGE; MICROBIOLOGY; PATHOLOGY; T LYMPHOCYTE; TREATMENT FAILURE; TUBERCULOSIS, PULMONARY; VACCINATION;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; BCG VACCINE; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; LUNG; LYMPH NODES; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES; TREATMENT FAILURE; TUBERCULOSIS, PULMONARY; VACCINATION;

EID: 84920057801     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2014.09.003     Document Type: Review

References (247)

1. Horsburgh C.R., Rubin E.J. Latent tuberculosis infection in the United States. N Engl J Med 2011, 364:1441-1448.
2. North R.J., Jung Y.-J. Immunity to tuberculosis. Annu Rev Immunol 2004, 22:599-623.
3. Chackerian A.A., Alt J.M., Perera T.V., Dascher C.C., Behar S. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect Immun 2002, 70:4501-4509.
4. Tian T., Woodworth J., Sköld M., Behar S. In vivo depletion of CD11c+ cells delays the CD4+ T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection. J Immunol 2005, 175:3268-3272.
5. Hanekom W.A., Mendillo M., Manca C., Haslett P.A.J., Siddiqui M.R., Barry C., et al. Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro. J Infect Dis 2003, 188:257-266.
6. Wolf A.J., Linas B., Trevejo-Nunez G.J., Kincaid E., Tamura T., Takatsu K., et al. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol 2007, 179:2509-2519.
7. Myers A.J., Marino S., Kirschner D.E., Flynn J.L. Inoculation dose of Mycobacterium tuberculosis does not influence priming of T cell responses in lymph nodes. J Immunol 2013, 190:4707-4716.
8. Winau F., Weber S., Sad S., de Diego J., Hoops S.L., Breiden B., et al. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 2006, 24:105-117.
9. Schaible U.E., Winau F., Sieling P.A., Fischer K., Collins H.L., Hagens K., et al. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med 2003, 9:1039-1046.
10. Divangahi M., Desjardins D., Nunes-Alves C., Remold H.G., Behar S. Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis. Nat Immunol 2010, 11:751-758.
11. Blomgran R., Ernst J.D. Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection. J Immunol 2011, 186:7110-7119.
12. Olmos S., Stukes S., Ernst J.D. Ectopic activation of Mycobacterium tuberculosis-specific CD4+ T cells in lungs of CCR7-/- mice. J Immunol 2010, 184:895-901.
13. Wolf A.J., Desvignes L., Linas B., Banaiee N., Tamura T., Takatsu K., et al. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J Exp Med 2008, 205:105-115.
14. Blomgran R., Desvignes L., Briken V., Ernst J.D. Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells. Cell Host Microbe 2012, 11:81-90.
15. Reiley W.W., Calayag M.D., Wittmer S.T., Huntington J.L., Pearl J.E., Fountain J.J., et al. ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proc Natl Acad Sci U S A 2008, 105:10961-10966.
16. Gallegos A.M., Pamer E.G., Glickman M.S. Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection. J Exp Med 2008, 205:2359-2368.
17. Samstein M., Schreiber H.A., Leiner I.M., Sušac B., Glickman M.S., Pamer E.G. Essential yet limited role for CCR2+ inflammatory monocytes during Mycobacterium tuberculosis-specific T cell priming. Elife 2013, 2:e01086.
18. Srivastava S., Ernst J.D. Cell-to-cell transfer of M. tuberculosis antigens optimizes CD4 T cell priming. Cell Host Microbe 2014, 15:741-752.
19. Hinchey J., Lee S., Jeon B.Y., Basaraba R.J., Venkataswamy M.M., Chen B., et al. Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. J Clin Invest 2007, 117:2279-2288.
20. Velmurugan K., Chen B., Miller J.L., Azogue S., Gurses S., Hsu T., et al. Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells. PLoS Pathog 2007, 3:e110.
21. Chen M., Divangahi M., Gan H., Shin D.S.J., Hong S., Lee D.M., et al. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J Exp Med 2008, 205:2791-2801.
22. Divangahi M., Chen M., Gan H., Desjardins D., Hickman T.T., Lee D.M., et al. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat Immunol 2009, 10:899-906.
23. Martin C.J., Booty M.G., Rosebrock T.R., Nunes-Alves C., Desjardins D.M., Keren I., et al. Efferocytosis is an innate antibacterial mechanism. Cell Host Microbe 2012, 12:289-300.
24. Farinacci M., Weber S., Kaufmann S.H.E. The recombinant tuberculosis vaccine rBCG δureC::hly+ induces apoptotic vesicles for improved priming of CD4+ and CD8+ T cells. Vaccine 2012, 30:7608-7614.
25. Nandi B., Behar S. Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection. J Exp Med 2011, 208:2251-2262.
26. Mishra B.B., Rathinam V.A.K., Martens G.W., Martinot A.J., Kornfeld H., Fitzgerald K.A., et al. Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β. Nat Immunol 2012, 14:52-60.
27. Seshadri C., Turner M.T., Lewinsohn D.M., Moody D.B., van Rhijn I. Lipoproteins are major targets of the polyclonal human T cell response to Mycobacterium tuberculosis. J Immunol 2012, 190:278-284.
28. Cohen N.R., Garg S., Brenner M.B. Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity. Adv Immunol 2009, 102:1-94.
29. Bold T.D., Banaei N., Wolf A.J., Ernst J.D. Suboptimal activation of antigen-specific CD4+ effector cells enables persistence of M. tuberculosis in vivo. PLoS Pathog 2011, 7:e1002063.
30. Aagaard C.S., Hoang T., Dietrich J., Cardona P.-J., Izzo A., Dolganov G., et al. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med 2011, 17:189-194.
31. Simeone R., Bottai D., Brosch R. ESX/type VII secretion systems and their role in host-pathogen interaction. Curr Opin Microbiol 2009, 12:4-10.
32. Sayes F., Sun L., Di Luca M., Simeone R., Degaiffier N., Fiette L., et al. Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion-encoded PE-PPE proteins predicts vaccine potential. Cell Host Microbe 2012, 11:352-363.
33. Garces A., Atmakuri K., Chase M.R., Woodworth J.S., Krastins B., Rothchild A.C., et al. EspA acts as a critical mediator of ESX1-dependent virulence in Mycobacterium tuberculosis by affecting bacterial cell wall integrity. PLoS Pathog 2010, 6:e1000957.
34. Woodworth J.S., Fortune S.M., Behar S. Bacterial protein secretion is required for priming of CD8+ T cells specific for the Mycobacterium tuberculosis antigen CFP10. Infect Immun 2008, 76:4199-4205.
35. Kunnath-Velayudhan S., Porcelli S.A. Recent advances in defining the immunoproteome of Mycobacterium tuberculosis. Front Immunol 2013, 4:335.
36. Woodworth J.S.M., Behar S. Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity. Crit Rev Immunol 2006, 26:317-352.
37. Woodworth J.S., Shin D., Volman M., Nunes-Alves C., Fortune S.M., Behar S. Mycobacterium tuberculosis directs immunofocusing of CD8+ T cell responses despite vaccination. J Immunol 2011, 186:1627-1637.
38. Hoang T.T.K.T., Nansen A., Roy S., Billeskov R., Aagaard C.S., Elvang T., et al. Distinct differences in the expansion and phenotype of TB10.4 specific CD8 and CD4 T cells after infection with Mycobacterium tuberculosis. PLoS ONE 2009, 4:e5928.
39. Kamath A., Woodworth J.S.M., Behar S. Antigen-specific CD8+ T cells and the development of central memory during Mycobacterium tuberculosis. Infection 2006, 177:6361-6369.
40. Kamath A.B., Woodworth J., Xiong X., Taylor C., Weng Y., Behar S. Cytolytic CD8+ T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection. J Exp Med 2004, 200:1479-1489.
41. Skjøt R.L.V., Brock I., Arend S.M., Munk M.E., Theisen M., Ottenhoff T.H.M., et al. Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family. Infect Immun 2002, 70:5446-5453.
42. Axelsson-Robertson R., Weichold F., Sizemore D., Wulf M., Skeiky Y.A.W., Sadoff J., et al. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8+ T-cell responses. Immunology 2009, 129:496-505.
43. Axelsson-Robertson R., Ahmed R.K., Weichold F.F., Ehlers M.M., Kock M.M., Sizemore D., et al. Human leukocyte antigens A*3001 and A*3002 show distinct peptide-binding patterns of the Mycobacterium tuberculosis protein TB10.4: consequences for immune recognition. Clin Vaccine Immunol 2011, 18:125-134.
44. Lindestam Arlehamn C.S., Gerasimova A., Mele F., Henderson R., Swann J., Greenbaum J.A., et al. Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subset. PLoS Pathog 2013, 9:e1003130.
45. Lewinsohn D.A., Winata E., Swarbrick G.M., Tanner K.E., Cook M.S., Null M.D., et al. Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B. PLoS Pathog 2007, 3:e127-e149.
46. Meier T., Eulenbruch H.P., Wrighton-Smith P., Enders G., Regnath T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 2005, 24:529-536.
47. Pottumarthy S., Morris A.J., Harrison A.C., Wells V.C. Evaluation of the tuberculin gamma interferon assay: potential to replace the Mantoux skin test. J Clin Microbiol 1999, 37:3229-3232.
48. Bellete B., Coberly J., Barnes G.L., Ko C., Chaisson R.E., Comstock G.W., et al. Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations. Clin Infect Dis 2002, 34:1449-1456.
49. Shams H., Klucar P., Weis S.E., Lalvani A., Moonan P.K., Safi H., et al. Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles. J Immunol 2004, 173:1966-1977.
50. Lindestam Arlehamn C.S., Sidney J., Henderson R., Greenbaum J.A., James E.A., Moutaftsi M., et al. Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ). J Immunol 2012, 188:5020-5031.
51. Wu Y., Woodworth J.S., Shin D.S., Morris S., Behar S. Vaccine-elicited 10-kilodalton culture filtrate protein-specific CD8+ T cells are sufficient to mediate protection against Mycobacterium tuberculosis infection. Infect Immun 2008, 76:2249-2255.
52. Korsholm K.S., Hansen J., Karlsen K., Filskov J., Mikkelsen M., Lindenstrøm T., et al. Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant. Vaccine 2014, 32:3927-3935.
53. Comas I., Chakravartti J., Small P.M., Galagan J., Niemann S., Kremer K., et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 2010, 42:498-503.
54. Woodworth J.S., Aagaard C.S., Hansen P.R., Cassidy J.P., Agger E.M., Andersen P. Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation. J Immunol 2014, 192:3247-3258.
55. Murugan A., Mora T., Walczak A.M., Callan C.G. Statistical inference of the generation probability of T-cell receptors from sequence repertoires. Proc Natl Acad Sci U S A 2012, 109:16161-16166.
56. Arstila T.P.T., Casrouge A.A., Baron V.V., Even J.J., Kanellopoulos J.J., Kourilsky P.P. A direct estimate of the human alphabeta T cell receptor diversity. Science 1999, 286:958-961.
57. Jenkins M.K., Chu H.H., McLachlan J.B., Moon J.J. On the composition of the preimmune repertoire of T cells specific for peptide - major histocompatibility complex ligands. Annu Rev Immunol 2010, 28:275-294.
58. Li H., Ye C., Ji G., Han J. Determinants of public T cell responses. Cell Res 2012, 22:33-42.
59. Busch D.H., Pamer E.G. T cell affinity maturation by selective expansion during infection. J Exp Med 1999, 189:701-710.
60. Du G., Chen C.Y., Shen Y., Qiu L., Huang D., Wang R., et al. TCR repertoire, clonal dominance, and pulmonary trafficking of mycobacterium-specific CD4+ and CD8+ T effector cells in immunity against tuberculosis. J Immunol 2010, 185:3940-3947.
61. Jacobsen M., Detjen A.K., Mueller H., Gutschmidt A., Leitner S., Wahn U., et al. Clonal expansion of CD8+ effector T cells in childhood tuberculosis. J Immunol 2007, 179:1331-1339.
62. Yang J., Xu K., Zheng J., Wei L., Fan J., Limited Li L. T cell receptor beta variable repertoire responses to ESAT-6 and CFP-10 in subjects infected with Mycobacterium tuberculosis. Tuberculosis (Edinb) 2013, 93:529-537.
63. Yang J., He J., Huang H., Ji Z., Wei L., Ye P., et al. Molecular characterization of T cell receptor beta variable in the peripheral blood T cell repertoire in subjects with active tuberculosis or latent tuberculosis infection. BMC Infect Dis 2013, 13:423.
64. Luo W., Su J., Zhang X.-B., Yang Z., Zhou M.-Q., Jiang Z.-M., et al. Limited T cell receptor repertoire diversity in tuberculosis patients correlates with clinical severity. PLoS ONE 2012, 7:e48117.
65. Tully G., Kortsik C., Höhn H., Zehbe I., Hitzler W.E., Neukirch C., et al. Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection. J Immunol 2005, 174:2174-2184.
66. Sharpe A.H., Freeman G.J. The B7-CD28 superfamily. Nat Rev Immunol 2002, 2:116-126.
67. Dolfi D.V., Duttagupta P.A., Boesteanu A.C., Mueller Y.M., Oliai C.H., Borowski A.B., et al. Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo. J Immunol 2011, 186:4599-4608.
68. Bhatt K., Uzelac A., Mathur S., McBride A., Potian J., Salgame P. B7 costimulation is critical for host control of chronic Mycobacterium tuberculosis infection. J Immunol 2009, 182:3793-3800.
69. Bhatt K., Kim A., Kim A., Mathur S., Salgame P. Equivalent functions for B7.1 and B7.2 costimulation in mediating host resistance to Mycobacterium tuberculosis. Cell Immunol 2013, 285:69-75.
70. Lancioni C.L., Li Q., Thomas J.J., Ding X., Thiel B., Drage M.G., et al. Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4+ T cell activation via Toll-like receptors 1 and 2. Infect Immun 2011, 79:663-673.
71. Reba S.M., Li Q., Onwuzulike S., Ding X., Karim A.F., Hernandez Y., et al. TLR2 engagement on CD4 +T cells enhances effector functions and protective responses to Mycobacterium tuberculosis. Eur J Immunol 2014, 44:1410-1421.
72. Li Q., Ding X., Thomas J.J., Harding C.V., Pecora N.D., Ziady A.G., et al. Rv2468c, a novel Mycobacterium tuberculosis protein that costimulates human CD4+ T cells through VLA-5. J Leukoc Biol 2012, 91:311-320.
73. Curtsinger J.M., Schmidt C.S., Mondino A., Lins D.C., Kedl R.M., Jenkins M.K., et al. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J Immunol 1999, 162:3256-3262.
74. Keppler S.J., Rosenits K., Koegl T., Vucikuja S., Aichele P. Signal 3 cytokines as modulators of primary immune responses during infections: the interplay of type I IFN and IL-12 in CD8 T cell responses. PLoS ONE 2012, 7:e40865.
75. Cooper A.M., Magram J., Ferrante J., Orme I.M. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J Exp Med 1997, 186:39-45.
76. Manca C., Tsenova L., Freeman S., Barczak A.K., Tovey M., Murray P.J., et al. Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J Interferon Cytokine Res 2005, 25:694-701.
77. Srivastava S., Ernst J.D. Cutting Edge: direct recognition of infected cells by CD4 T cells is required for control of intracellular Mycobacterium tuberculosis IN VIVO. J Immunol 2013, 191:1016-1020.
78. Schreiber T., Ehlers S., Aly S., Hölscher A., Hartmann S., Lipp M., et al. Selectin ligand-independent priming and maintenance of T cell immunity during airborne tuberculosis. J Immunol 2006, 176:1131-1140.
79. Taylor J.L., Bielefeldt-Ohmann H., Pozzi A., Izzo A.A. Lack of alpha-1 integrin alters lesion morphology during pulmonary Mycobacterium tuberculosis infection. Tuberculosis (Edinb) 2008, 88:444-452.
80. Ghosh S., Chackerian A.A., Parker C.M., Ballantyne C.M., Behar S. The LFA-1 adhesion molecule is required for protective immunity during pulmonary Mycobacterium tuberculosis infection. J Immunol 2006, 176:4914-4922.
81. Hu C., Mayadas-Norton T., Tanaka K., Chan J., Salgame P. Mycobacterium tuberculosis infection in complement receptor 3-deficient mice. J Immunol 2000, 165:2596-2602.
82. Johnson C.M., Cooper A.M., Frank A.A., Orme I.M. Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis-infected mice with a disruption in the intracellular adhesion molecule 1 gene. Infect Immun 1998, 66:1666-1670.
83. Lord G.M., Rao R.M., Choe H., Sullivan B.M., Lichtman A.H., Luscinskas F.W., et al. T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood 2005, 106:3432-3439.
84. Sakai S., Kauffman K.D., Schenkel J.M., McBerry C.C., Mayer-Barber K.D., Masopust D., et al. Cutting Edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells. J Immunol 2014, 192:2965-2969.
85. Seiler P., Aichele P., Bandermann S., Hauser A.E., Lu B., Gerard N.P., et al. Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines. Eur J Immunol 2003, 33:2676-2686.
86. Chakravarty S.D., Xu J., Lu B., Gerard C., Flynn J., Chan J. The chemokine receptor CXCR3 attenuates the control of chronic Mycobacterium tuberculosis infection in BALB/c mice. J Immunol 2007, 178:1723-1735.
87. Algood H.M.S., Flynn J.L. CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J Immunol 2004, 173:3287-3296.
88. Kohlmeier J.E., Reiley W.W., Perona-Wright G., Freeman M.L., Yager E.J., Connor L.M., et al. Inflammatory chemokine receptors regulate CD8+ T cell contraction and memory generation following infection. J Exp Med 2011, 208:1621-1634.
89. Hall J.D., Kurtz S.L., Rigel N.W., Gunn B.M., Taft-Benz S., Morrison J.P., et al. The impact of chemokine receptor CX3CR1 deficiency during respiratory infections with Mycobacterium tuberculosis or Francisella tularensis. Clin Exp Immunol 2009, 156:278-284.
90. Day T.A., Koch M., Nouailles G., Jacobsen M., Kosmiadi G.A., Miekley D., et al. Secondary lymphoid organs are dispensable for the development of T-cell-mediated immunity during tuberculosis. Eur J Immunol 2010, 40:1663-1673.
91. Kahnert A., Höpken U.E., Stein M., Bandermann S., Lipp M., Kaufmann S.H.E. Mycobacterium tuberculosis triggers formation of lymphoid structure in murine lungs. J Infect Dis 2007, 195:46-54.
92. Gopal R., Rangel-Moreno J., Slight S., Lin Y., Nawar H.F., Fallert Junecko B.A., et al. Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis. Mucosal Immunol 2013, 6:972-984.
93. + T helper cells mediate protective immunity against tuberculosis. J Clin Invest 2013, 123:712-726.
94. Anderson K.G., Mayer-Barber K., Sung H., Beura L., James B.R., Taylor J.J., et al. Intravascular staining for discrimination of vascular and tissue leukocytes. Nat Protoc 2014, 9:209-222.
95. Ehlers S., Benini J., Held H.D., Roeck C., Alber G., Uhlig S. Alphabeta T cell receptor-positive cells and interferon-gamma, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology. J Exp Med 2001, 194:1847-1859.
96. Feng C.G., Jankovic D., Kullberg M., Cheever A., Scanga C.A., Hieny S., et al. Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production. J Immunol 2005, 174:4185-4192.
97. Lin P.L., Rutledge T., Green A.M., Bigbee M., Fuhrman C., Klein E., et al. CD4 T cell depletion exacerbates acute Mycobacterium tuberculosis while reactivation of latent infection is dependent on severity of tissue depletion in cynomolgus macaques. AIDS Res Hum Retroviruses 2012, 28:1693-1702.
98. Scanga C.A., Mohan V.P., Yu K., Joseph H., Tanaka K., Chan J., et al. Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J Exp Med 2000, 192:347-358.
99. Diedrich C.R., Mattila J.T., Klein E., Janssen C., Phuah J., Sturgeon T.J., et al. Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load. PLoS ONE 2010, 5:e9611.
100. Flory C.M., Hubbard R.D., Collins F.M. Effects of in vivo T lymphocyte subset depletion on mycobacterial infections in mice. J Leukoc Biol 1992, 51:225-229.
101. Geldmacher C., Zumla A., Hoelscher M. Interaction between HIV and Mycobacterium tuberculosis: HIV-1-induced CD4 T-cell depletion and the development of active tuberculosis. Curr Opin HIV AIDS 2012, 7:268-275.
102. Weiss D.W., Dubos R.J. Antituberculous immunity induced in mice by vaccination with killed tubercle bacilli or with a soluble bacillary extract. J Exp Med 1955, 101:313-330.
103. Shen Y., Zhou D., Zhou D., Qiu L., Lai X., Lai X., et al. Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science 2002, 295:2255-2258.
104. Chen C.Y., Yao S., Huang D., Wei H., Sicard H., Zeng G., et al. Phosphoantigen/IL2 expansion and differentiation of Vγ2Vδ2T cells increase resistance to tuberculosis in nonhuman primates. PLoS Pathog 2013, 9:e1003501.
105. Behar S., Boom W.H. Unconventional T cells. Handbook of tuberculosis 2008, Wiley-VCH, Weinheim.
106. Einarsdottir T., Lockhart E., Flynn J.L. Cytotoxicity and secretion of gamma interferon are carried out by distinct CD8 T cells during Mycobacterium tuberculosis infection. Infect Immun 2009, 77:4621-4630.
107. Behar S., Porcelli S.A. CD1-restricted T cells in host defense to infectious diseases. Curr Top Microbiol Immunol 2007, 314:215-250.
108. Van Rhijn I., Kasmar A., de Jong A., Gras S., Bhati M., Doorenspleet M.E., et al. A conserved human T cell population targets mycobacterial antigens presented by CD1b. Nat Immunol 2013, 14:706-713.
109. Sada-Ovalle I., Chiba A., Gonzales A., Brenner M.B., Behar S. Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. PLoS Pathog 2008, 4:e1000239.
110. Rothchild A.C., Jayaraman P., Nunes-Alves C., Behar S. iNKT cell production of GM-CSF controls Mycobacterium tuberculosis. PLoS Pathog 2014, 10:e1003805.
111. Gold M.C., Ehlinger H.D., Cook M.S., Smyk-Pearson S.K., Wille P.T., Ungerleider R.M., et al. Human innate Mycobacterium tuberculosis-reactive alphabetaTCR+ thymocytes. PLoS Pathog 2008, 4:e39.
112. Gold M.C., Cerri S., Smyk-Pearson S., Cansler M.E., Vogt T.M., Delepine J., et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol 2010, 8:e1000407.
113. Mogues T., Goodrich M.E., Ryan L., LaCourse R., North R.J. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med 2001, 193:271-280.
114. Yao S., Huang D., Chen C.Y., Halliday L., Wang R.C., Chen Z.W. CD4+ T cells contain early extrapulmonary tuberculosis (TB) dissemination and rapid TB progression and sustain multieffector functions of CD8+ T and CD3- lymphocytes: mechanisms of CD4+ T cell immunity. J Immunol 2014, 192:2120-2132.
115. Chen C.Y., Huang D., Wang R.C., Shen L., Zeng G., Yao S., et al. A critical role for CD8 T cells in a nonhuman primate model of tuberculosis. PLoS Pathog 2009, 5:e1000392.
116. Lockhart E., Green A.M., Flynn J.L. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 2006, 177:4662-4669.
117. Cruz A., Fraga A.G., Fountain J.J., Rangel-Moreno J., Torrado E., Saraiva M., et al. Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J Exp Med 2010, 207:1609-1616.
118. Wozniak T.M., Saunders B.M., Ryan A.A., Britton W.J. Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon. Infect Immun 2010, 78:4187-4194.
119. Okamoto Yoshida Y., Umemura M., Yahagi A., O'Brien R.L., Ikuta K., Kishihara K., et al. Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J Immunol 2010, 184:4414-4422.
120. Cruz A., Khader S.A., Torrado E., Fraga A., Pearl J.E., Pedrosa J., et al. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 2006, 177:1416-1420.
121. Flynn J.L., Goldstein M.M., Triebold K.J., Koller B., Bloom B.R. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A 1992, 89:12013-12017.
122. Behar S., Dascher C.C., Grusby M.J., Wang C.R., Brenner M.B. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med 1999, 189:1973-1980.
123. van Pinxteren L.A., Cassidy J.P., Smedegaard B.H., Agger E.M., Andersen P. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol 2000, 30:3689-3698.
124. Green A.M., DiFazio R., Flynn J.L. IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection. J Immunol 2012, 190:270-277.
125. Serbina N.V., Lazarevic V., Flynn J.L. CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection. J Immunol 2001, 167:6991-7000.
126. Bold T.D., Ernst J.D. CD4+ T cell-dependent IFN-γ production by CD8+ effector T cells in Mycobacterium tuberculosis infection. J Immunol 2012, 189:2530-2536.
127. Precopio M.L., Betts M.R., Parrino J., Price D.A., Gostick E., Ambrozak D.R., et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J Exp Med 2007, 204:1405-1416.
128. Wherry E.J., Ha S-J., Kaech S.M., Haining W.N., Sarkar S., Kalia V., et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 2007, 27:670-684.
129. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006, 439:682-687.
130. Qiu Z., Zhang M., Zhu Y., Zheng F., Lu P., Liu H., et al. Multifunctional CD4 T cell responses in patients with active tuberculosis. Sci Rep 2012, 2:216.
131. Rozot V., Vigano S., Mazza-Stalder J., Idrizi E., Day C.L., Perreau M., et al. Mycobacterium tuberculosis-specific CD8 +T cells are functionally and phenotypically different between latent infection and active disease. Eur J Immunol 2013, 43:1568-1577.
132. Day C.L., Mkhwanazi N., Reddy S., Mncube Z., van der Stok M., Klenerman P., et al. Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons. J Infect Dis 2008, 197:990-999.
133. Day C.L., Abrahams D.A., Lerumo L., Janse Van Rensburg E., Stone L., O'rie T., et al. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J Immunol 2011, 187:2222-2232.
134. Day C.L., Moshi N.D., Abrahams D.-A., van Rooyen M., O'rie T., de Kock M., et al. Patients with tuberculosis disease have Mycobacterium tuberculosis-specific CD8 T cells with a pro-apoptotic phenotype and impaired proliferative capacity, which is not restored following treatment. PLoS ONE 2014, 9:e94949.
135. Douvas G.S., Looker D.L., Vatter A.E., Crowle A.J. Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect Immun 1985, 50:1-8.
136. Hu X., Herrero C., Li W-P., Antoniv T.T., Falck-Pedersen E., Koch A.E., et al. Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation. Nat Immunol 2002, 3:859-866.
137. Gallegos A.M., Van Heijst J.W.J., Samstein M., Su X., Pamer E.G., Glickman M.S. A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo. PLoS Pathog 2011, 7:e1002052.
138. Caruso A.M., Serbina N., Klein E., Triebold K., Bloom B.R., Flynn J.L. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol 1999, 162:5407-5416.
139. Jayaraman P., Sada-Ovalle I., Nishimura T., Anderson A.C., Kuchroo V.K., Remold H.G., et al. IL-1 promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation. J Immunol 2013, 190:4196-4204.
140. Balcewicz-Sablinska M.K., Keane J., Kornfeld H., Remold H.G. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J Immunol 1998, 161:2636-2641.
141. Allie N., Grivennikov S.I., Keeton R., Hsu N-J., Bourigault M-L., Court N., et al. Prominent role for T cell-derived tumour necrosis factor for sustained control of Mycobacterium tuberculosis infection. Sci Rep 2013, 3:1809.
142. Denis M., Ghadirian E. Granulocyte-macrophage colony-stimulating factor restricts growth of tubercle bacilli in human macrophages. Immunol Lett 1990, 24:203-206.
143. Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol 1991, 49:380-387.
144. Szeliga J., Daniel D.S., Yang C-H., Sever-Chroneos Z., Jagannath C., Chroneos Z.C. Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis. Tuberculosis (Edinb) 2008, 88:7-20.
145. Gonzalez-Juarrero M., Hattle J.M., Izzo A., Junqueira-Kipnis A.P., Shim T.S., Trapnell B.C., et al. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J Leukoc Biol 2005, 77:914-922.
146. Mueller H., Detjen A.K., Schuck S.D., Gutschmidt A., Wahn U., Magdorf K., et al. Mycobacterium tuberculosis-specific CD4+, IFNgamma+, and TNFalpha+ multifunctional memory T cells coexpress GM-CSF. Cytokine 2008, 43:143-148.
147. Rosen L.B., Freeman A.F., Yang L.M., Jutivorakool K., Olivier K.N., Angkasekwinai N., et al. Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis. J Immunol 2013, 190:3959-3966.
148. Skinner M.A., Parlane N., McCarthy A., Buddle B.M. Cytotoxic T-cell responses to Mycobacterium bovis during experimental infection of cattle with bovine tuberculosis. Immunology 2003, 110:234-241.
149. Pathan A.A., Wilkinson K.A., Wilkinson R.J., Latif M., Mcshane H., Pasvol G., et al. High frequencies of circulating IFN-gamma-secreting CD8 cytotoxic T cells specific for a novel MHC class I-restricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease. Eur J Immunol 2000, 30:2713-2721.
150. Woodworth J.S., Wu Y., Behar S. Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo. J Immunol 2008, 181:8595-8603.
151. Turner J., D'Souza C.D., Pearl J.E., Marietta P., Noel M., Frank A.A., et al. CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis. Am J Respir Cell Mol Biol 2001, 24:203-209.
152. Sousa A.O., Mazzaccaro R.J., Russell R.G., Lee F.K., Turner O.C., Hong S., et al. Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc Natl Acad Sci U S A 2000, 97:4204-4208.
153. Stenger S., Hanson D.A., Teitelbaum R., Dewan P., Niazi K.R., Froelich C.J., et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998, 282:121-125.
154. Behar S., Divangahi M., Remold H.G. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?. Nat Rev Microbiol 2010, 8:668-674.
155. Pipkin M.E., Sacks J.A., Cruz-Guilloty F., Lichtenheld M.G., Bevan M.J., Rao A. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 2010, 32:79-90.
156. Chen C.Y., Huang D., Yao S., Halliday L., Zeng G., Wang R.C., et al. IL-2 simultaneously expands Foxp3+ T regulatory and T effector cells and confers resistance to severe tuberculosis (TB): implicative Treg-T effector cooperation in immunity to TB. J Immunol 2012, 188:4278-4288.
157. Saunders B.M., Frank A.A., Orme I.M., Cooper A.M. CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis. Cell Immunol 2002, 216:65-72.
158. Saunders B.M., Britton W.J. Life and death in the granuloma: immunopathology of tuberculosis. Immunol Cell Biol 2007, 85:103-111.
159. Lawn S.D., Butera S.T., Shinnick T.M. Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis. Microbes Infect 2002, 4:635-646.
160. Kwan C.K., Ernst J.D. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev 2011, 24:351-376.
161. Pearl J.E., Torrado E., Tighe M., Fountain J.J., Solache A., Strutt T., et al. Nitric oxide inhibits the accumulation of CD4+CD44 hiTbet+CD69 loT cells in mycobacterial infection. Eur J Immunol 2012, 42:3267-3279.
162. Cooper A., Adams L.B., Dalton D.K., Appelberg R., Ehlers S. IFN-gamma and NO in mycobacterial disease: new jobs for old hands. Trends Microbiol 2002, 10:221-226.
163. Beamer G.L., Flaherty D.K., Assogba B.D., Stromberg P., Gonzalez-Juarrero M., De Waal Malefyt R., et al. Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. J Immunol 2008, 181:5545-5550.
164. North R.J. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin Exp Immunol 1998, 113:55-58.
165. Pitt J.M., Stavropoulos E., Redford P.S., Beebe A.M., Bancroft G.J., Young D.B., et al. Blockade of IL-10 signaling during Bacillus calmette-guerin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection. J Immunol 2012, 189:4079-4087.
166. Plotkin S.A. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010, 17:1055-1065.
167. Fine P.E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995, 346:1339-1345.
168. Ottenhoff T.H.M., Kaufmann S.H.E. Vaccines against tuberculosis: where are we and where do we need to go?. PLoS Pathog 2012, 8:e1002607.
169. Rowland R., McShane H. Tuberculosis vaccines in clinical trials. Expert Rev Vaccines 2011, 10:645-658.
170. Tameris M.D., Hatherill M., Landry B.S., Scriba T.J., Snowden M.A., Lockhart S., et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 2013, 381:1021-1028.
171. Black G.F., Dockrell H.M., Crampin A.C., Floyd S., Weir R.E., Bliss L., et al. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J Infect Dis 2001, 184:322-329.
172. Brandt L., Feino Cunha J., Weinreich Olsen A., Chilima B., Hirsch P., Appelberg R., et al. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 2002, 70:672-678.
173. Elias D., Britton S., Aseffa A., Engers H., Akuffo H. Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-β production. Vaccine 2008, 26:3897-3902.
174. Harrington L.E., Janowski K.M., Oliver J.R., Zajac A.J., Weaver C.T. Memory CD4 T cells emerge from effector T-cell progenitors. Nature 2008, 452:356-360.
175. Kaech S.M., Wherry E.J., Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002, 2:251-262.
176. Orme I.M. Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. J Immunol 1988, 140:3589-3593.
177. Opferman J.T., Ober B.T., Ashton-Rickardt P.G. Linear differentiation of cytotoxic effectors into memory T lymphocytes. Science 1999, 283:1745-1748.
178. Wherry E.J., Teichgräber V., Becker T.C., Masopust D., Kaech S.M., Antia R., et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003, 4:225-234.
179. Kaech S.M., Hemby S., Kersh E., Ahmed R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 2002, 111:837-851.
180. Huster K.M., Busch V., Schiemann M., Linkemann K., Kerksiek K.M., Wagner H., et al. Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc Natl Acad Sci U S A 2004, 101:5610-5615.
181. McKinstry K.K., Golech S., Lee W.H., Huston G., Weng N.P., Swain S.L. Rapid default transition of CD4 T cell effectors to functional memory cells. J Exp Med 2007, 204:2199-2211.
182. Henao-Tamayo M., Ordway D.J., Orme I.M. Memory T cell subsets in tuberculosis: What should we be targeting?. Tuberculosis (Edinb) 2014, 94:455-461.
183. Jameson S.C., Masopust D. Diversity in T cell memory: an embarrassment of riches. Immunity 2009, 31:859-871.
184. Weng N-P., Araki Y., Subedi K. The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation. Nat Rev Immunol 2012, 12:306-315.
185. Olsen A.W., Williams A., Okkels L.M., Hatch G., Andersen P. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect Immun 2004, 72:6148-6150.
186. Desel C., Dorhoi A., Bandermann S., Grode L., Eisele B., Kaufmann S.H.E. Recombinant BCG ureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses. J Infect Dis 2011, 204:1573-1584.
187. Lin P.L., Dietrich J., Tan E., Abalos R.M., Burgos J., Bigbee C., et al. The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. J Clin Invest 2012, 122:303-314.
188. Bertholet S., Ireton G.C., Ordway D.J., Windish H.P., Pine S.O., Kahn M., et al. A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis. Sci Transl Med 2010, 2. 53ra74-ra54.
189. Cooper A.M., Callahan J.E., Keen M., Belisle J.T., Orme I.M. Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis. Tuber Lung Dis 1997, 78:67-73.
190. Jung Y-J., Ryan L., LaCourse R., North R.J. Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice. J Exp Med 2005, 201:1915-1924.
191. Kamath A.B., Behar S. Anamnestic responses of mice following Mycobacterium tuberculosis infection. Infect Immun 2005, 73:6110-6118.
192. Millet J.-P., Shaw E., Orcau A., Casals M., Miró J.M., Caylà J.A., et al. Tuberculosis recurrence after completion treatment in a European City: reinfection or relapse?. PLoS ONE 2013, 8:e64898.
193. Crofts J.P., Andrews N.J., Barker R.D., Delpech V., Abubakar I. Risk factors for recurrent tuberculosis in England and Wales, 1998-2005. Thorax 2010, 65:310-314.
194. Dobler C.C., Crawford A.B.H., Jelfs P.J., Gilbert G.L., Marks G.B. Recurrence of tuberculosis in a low-incidence setting. Eur Respir J 2009, 33:160-167.
195. van Rie A., Warren R., Richardson M., Victor T.C., Gie R.P., Enarson D.A., et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999, 341:1174-1179.
196. Jeong Y.H., Jeon B.Y., Gu S.H., Cho S.N., Shin S-J., Chang J., et al. Differentiation of antigen-specific T cells with limited functional capacity during Mycobacterium tuberculosis infection. Infect Immun 2013, 82:132-139.
197. Joshi N.S., Cui W., Chandele A., Lee H.K., Urso D.R., Hagman J., et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 2007, 27:281-295.
198. Jeong Y.H., Jeon B.Y., Gu S.H., Cho S.N., Shin S-J., Chang J., et al. Differentiation of antigen-specific T cells with limited functional capacity during Mycobacterium tuberculosis infection. Infect Immun 2014, 82:3514-3524.
199. Andrews J.R., Noubary F., Walensky R.P., Cerda R., Losina E., Horsburgh C.R. Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin Infect Dis 2012, 54:784-791.
200. Adekambi T., Ibegbu C.C., Kalokhe A.S., Yu T., Ray S.M., Rengarajan J. Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis. PLoS ONE 2012, 7:e36046.
201. Andersen P., Woodworth J.S. Tuberculosis vaccines - rethinking the current paradigm. Trends Immunol 2014, 35:387-395.
202. Nunes-Alves C., Booty M.G., Carpenter S.M., Jayaraman P., Rothchild A.C., Behar S. In search of a new paradigm for protective immunity to TB. Nat Rev Microbiol 2014, 12:289-299.
203. Schwartz R.H. T cell anergy. Annu Rev Immunol 2003, 21:305-334.
204. Tanchot C., Guillaume S., Delon J., Bourgeois C., Franzke A., Sarukhan A., et al. Modifications of CD8+ T cell function during in vivo memory or tolerance induction. Immunity 1998, 8:581-590.
205. Tanchot C., Barber D.L., Chiodetti L., Schwartz R.H. Adaptive tolerance of CD4+ T cells in vivo: multiple thresholds in response to a constant level of antigen presentation. J Immunol 2001, 167:2030-2039.
206. Kalia V., Sarkar S., Ahmed R. CD8 T-cell memory differentiation during acute and chronic viral infections. Memory T cells 2010, vol. 684:79-95. Springer, New York, NY.
207. Kim P.S., Ahmed R. Features of responding T cells in cancer and chronic infection. Curr Opin Immunol 2010, 22:223-230.
208. Wherry E.J. T cell exhaustion. Nat Immunol 2011, 131:492-499.
209. Szabo S.J., Sullivan B.M., Stemmann C., Satoskar A.R., Sleckman B.P., Glimcher L.H. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 2002, 295:338-342.
210. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100:655-669.
211. Crawford A., Angelosanto J.M., Kao C., Doering T.A., Odorizzi P.M., Barnett B.E., et al. Molecular and transcriptional basis of CD4+ T cell dysfunction during chronic infection. Immunity 2014, 40:289-302.
212. Harari A., Rozot V., Enders F.B., Perreau M., Stalder J.M., Nicod L.P., et al. Dominant TNF-α+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med 2011, 17:372-376.
213. Perreau M., Rozot V., Welles H.C., Belluti-Enders F., Vigano S., Maillard M., et al. Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active disease. Eur J Immunol 2013, 43:939-948.
214. Youngblood B., Wherry E.J., Ahmed R. Acquired transcriptional programming in functional and exhausted virus-specific CD8 T cells. Curr Opin HIV AIDS 2012, 7:50-57.
215. Brahmer J.R., Tykodi S.S., Chow L.Q.M., Hwu W-J., Topalian S.L., Hwu P., et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 2012, 366:2455-2465.
216. Topalian S.L., Hodi F.S., Brahmer J.R., Gettinger S.N., Smith D.C., McDermott D.F., et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012, 366:2443-2454.
217. Qiu Y., Chen J., Liao H., Zhang Y., Wang H., Li S., et al. Tim-3-expressing CD4+ and CD8+ T cells in human tuberculosis (TB) exhibit polarized effector memory phenotypes and stronger anti-TB effector functions. PLoS Pathog 2012, 8:e1002984.
218. Yang B., Wang X., Jiang J., Cheng X. Involvement of CD244 in regulating CD4+ T cell immunity in patients with active tuberculosis. PLoS ONE 2013, 8:e63261.
219. Jurado J.O., Alvarez I.B., Pasquinelli V., Martínez G.J., Quiroga M.F., Abbate E., et al. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J Immunol 2008, 181:116-125.
220. Alvarez I.B., Pasquinelli V., Jurado J.O., Abbate E., Musella R.M., la Barrera de S.S., et al. Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis. J Infect Dis 2010, 202:524-532.
221. Jiang J., Wang X., An H., Yang B., Cao Z., Liu Y., et al. Mucosal-associated invariant T-cell function is modulated by programmed death-1 signaling in patients with active tuberculosis. Am J Respir Crit Care Med 2014, 190:329-339.
222. Lazar-Molnar E., Chen B., Sweeney K.A., Wang E.J., Liu W., Lin J., et al. Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc Natl Acad Sci U S A 2010, 107:13402-13407.
223. Barber D.L., Mayer-Barber K.D., Feng C.G., Sharpe A.H., Sher A. CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition. J Immunol 2011, 186:1598-1607.
224. Henao-Tamayo M., Irwin S.M., Shang S., Ordway D., Orme I.M. T lymphocyte surface expression of exhaustion markers as biomarkers of the efficacy of chemotherapy for tuberculosis. Tuberculosis (Edinb) 2011, 91:308-313.
225. Singh A., Mohan A., Dey A.B., Mitra D.K. Inhibiting the programmed death 1 pathway rescues Mycobacterium tuberculosis-specific interferon γ-producing T cells from apoptosis in patients with pulmonary tuberculosis. J Infect Dis 2013, 208:603-615.
226. Jones R.B., Ndhlovu L.C., Barbour J.D., Sheth P.M., Jha A.R., Long B.R., et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 2008, 205:2763-2779.
227. Golden-Mason L., Palmer B.E., Kassam N., Townshend-Bulson L., Livingston S., Mcmahon B.J., et al. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J Virol 2009, 83:9122-9130.
228. Sakuishi K., Apetoh L., Sullivan J.M., Blazar B.R., Kuchroo V.K., Anderson A.C., et al. PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med 2010, 207:2187-2194.
229. Wang X., Cao Z., Jiang J., Li Y., Dong M., Ostrowski M., et al. Elevated expression of Tim-3 on CD8 T cells correlates with disease severity of pulmonary tuberculosis. J Infect 2011, 62:292-300.
230. Jayaraman P., Sada-Ovalle I., Beladi S., Anderson A.C., Dardalhon V., Hotta C., et al. Tim3 binding to galectin-9 stimulates antimicrobial immunity. J Exp Med 2010, 207:2343-2354.
231. Sada-Ovalle I., Chávez-Galán L., Torre-Bouscoulet L., Nava-Gamino L., Barrera L., Jayaraman P., et al. The Tim3-galectin 9 pathway induces antibacterial activity in human macrophages infected with Mycobacterium tuberculosis. J Immunol 2012, 189:5896-5902.
232. Urdahl K.B., Shafiani S., Ernst J.D. Initiation and regulation of T-cell responses in tuberculosis. Mucosal Immunol 2011, 4:288-293.
233. Shafiani S., Dinh C., Ertelt J.M., Moguche A.O., Siddiqui I., Smigiel K.S., et al. Pathogen-specific Treg cells expand early during Mycobacterium tuberculosis infection but are later eliminated in response to interleukin-12. Immunity 2013, 38:1261-1270.
234. Shafiani S., Tucker-Heard G., Kariyone A., Takatsu K., Urdahl K.B. Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med 2010, 207:1409-1420.
235. Guyot-Revol V., Innes J.A., Hackforth S., Hinks T., Lalvani A. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 2006, 173:803-810.
236. Ribeiro-Rodrigues R., Resende Co T., Rojas R., Toossi Z., Dietze R., Boom W.H., et al. A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis. Clin Exp Immunol 2006, 144:25-34.
237. Chen X., Zhou B., Li M., Deng Q., Wu X., Le X., et al. CD4+CD25+FoxP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 2007, 123:50-59.
238. Elahi S., Dinges W.L., Lejarcegui N., Laing K.J., Collier A.C., Koelle D.M., et al. Protective HIV-specific CD8+ T cells evade Treg cell suppression. Nat Med 2011, 17:989-995.
239. Sakuishi K., Ngiow S.F., Sullivan J.M., Teng M.W.L., Kuchroo V.K., Smyth M.J., et al. TIM3+FOXP3+ regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer. Oncoimmunology 2013, 2:e23849.
240. Toossi Z., Gogate P., Shiratsuchi H., Young T., Ellner J.J. Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. J Immunol 1995, 154:465-473.
241. Boussiotis V.A., Tsai E.Y., Yunis E.J., Thim S., Delgado J.C., Dascher C.C., et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000, 105:1317-1325.
242. Moore K.W., De Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
243. Modolell M., Choi B-S., Ryan R.O., Hancock M., Titus R.G., Abebe T., et al. Local suppression of T cell responses by arginase-induced l-arginine depletion in nonhealing leishmaniasis. PLoS Negl Trop Dis 2009, 3:e480-e490.
244. Zea A.H., Culotta K.S., Ali J., Mason C., Park H-J., Zabaleta J., et al. Decreased expression of CD3zeta and nuclear transcription factor kappa B in patients with pulmonary tuberculosis: potential mechanisms and reversibility with treatment. J Infect Dis 2006, 194:1385-1393.
245. Lin P.L., Ford C.B., Coleman M.T., Myers A.J., Gawande R., Ioerger T., et al. Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat Med 2013, 20:75-79.
246. Via L.E., Lin P.L., Ray S.M., Carrillo J., Allen S.S., Eum S.Y., et al. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 2008, 76:2333-2340.
247. West E.E., Youngblood B., Tan W.G., Jin H-T., Araki K., Alexe G., et al. Tight regulation of memory CD8+ T cells limits their effectiveness during sustained high viral load. Immunity 2011, 35:285-298.